Edelfosine, apoptosis, MDR and Na+/H+ exchanger: induction mechanisms and treatment implications.
Department of Medical Oncology, Clinica La Esperanza, Vitoria, Spain. sharguindey@jet.es
S
S
Harguindey
J L
JL
Pedraz
R G
RG
Cañero
M
M
Katin
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis; D018432:Drug Resistance, Multiple; D010742:Phospholipid Ethers / Q000627:therapeutic use*; D017923:Sodium-Hydrogen Exchangers
D000970:Antineoplastic Agents; D010742:Phospholipid Ethers; D017923:Sodium-Hydrogen Exchangers; C026659:edelfosine